Hepatorenal Syndrome: Diagnose in a Changing Circulation

Student Handouts and Nephrology Primer · Visual teaching summary · October 3, 2026

Andrew Bland, MD, FACP, FAAP

Visual summary

Liver transplant assessment, kidney replacement decisions, and supportive care should reflect reversibility, overall illness, and patient priorities.

Cirrhotic circulation can reduce effective kidney perfusion. See the diagram description and full text below.
· Download full-size illustration (PNG) · Download Markdown · Read text version ·

Illustration updated October 18, 2026. Educational schematic. Imaging and microscopy panels are illustrations, not patient studies. Full teaching text and sources follow.

Diagram description

Cirrhotic circulation can reduce effective kidney perfusion. Portal hypertension — Initiates circulatory change; Splanchnic vasodilation — Effective arterial filling falls; Neurohormonal response — RAAS and sympathetic activation; Renal vasoconstriction — Filtration can decline. Cirrhotic AKI has several causes. Assess alternatives and response before assigning HRS. The infographic uses anatomical illustrations and integrated labels; the complete teaching text and evidence are below.

Text version

Systemic vasodilation and kidney perfusion

Advanced liver disease can reduce effective arterial filling and provoke renal vasoconstriction. Infection, bleeding, congestion, and intrinsic injury may coexist.

Recognize the trigger

A rising creatinine, reduced urine output, or changing volume status in cirrhosis calls for a rapid search for reversible causes.

Use the 2024 ADQI–ICA framework

Consider HRS-AKI in cirrhosis with ascites and dynamic AKI when function does not improve after adequate resuscitation when indicated, and no stronger alternative primary cause explains the injury. Evaluate infection, nephrotoxins, obstruction, and structural injury. HRS physiology can coexist with other kidney disease.

Do not require automatic 48-hour albumin

Current consensus does not require routine albumin administration for 48 hours before diagnosing HRS-AKI. Assess volume first and reevaluate an indicated resuscitation response promptly. Once diagnosed, vasoactive therapy with albumin requires individualized dosing and ongoing reassessment of oxygenation and fluid overload.

Watch respiratory and circulatory risk

Volume expansion and vasoconstrictor treatment can have important harms. Reevaluate congestion, oxygenation, perfusion, and response.

Connect to prognosis and goals

Liver transplant assessment, kidney replacement decisions, and supportive care should reflect reversibility, overall illness, and patient priorities.

Supporting evidence

Continue learning